Abiopharma

📋 MICHELLE GRIFFIN (Director) plans to sell 15K shares of ADAPTIVE BIOTECHNOLOGIES CORPORATION (at $13.91 each, total $214K) Filed: Mar 11, 2026 | ID: 002479

Calhoun Lesley Ann 🟢 acquired 37.5K shares (1 derivative) of Aligos Therapeutics, Inc. (ALGS) at $7.03 Transaction Date: Mar 09, 2026 | Filing ID: 000093

BLATT LAWRENCE 🟢 acquired 105.8K shares (1 derivative) of Aligos Therapeutics, Inc. (ALGS) at $7.03 Transaction Date: Mar 09, 2026 | Filing ID: 000092

(90% Positive) FOGHORN THERAPEUTICS INC. (FHTX) Announces Enrollment Update for financing Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

📋 TRENT G KAMKE (Officer) plans to sell 3K shares of LEMAITRE VASCULAR, INC. (at $108.50 each, total $285K) Filed: Mar 11, 2026 | ID: 002460

📋 Ullem Scott B. (Officer) plans to sell 26K shares of Edwards Lifesciences Corp (at $84.92 each, total $2.2M) Filed: Mar 11, 2026 | ID: 000303

Rajangam Kanya 🔴 sold 10.8K shares of Senti Biosciences, Inc. (SNTI) Transaction Date: Mar 09, 2026 | Filing ID: 016795

Director Lu Timothy K 🔴 sold 80.7K shares of Senti Biosciences, Inc. (SNTI) Transaction Date: Mar 09, 2026 | Filing ID: 016794

Durbin Sean 🟡 adjusted position in 31.9K shares (15 derivative) of LINDE PLC (LIN) at $484.74 ($32.4M) Transaction Date: Mar 09, 2026 | Filing ID: 000002

PERCEPTIVE ADVISORS LLC 🟢 acquired 8.9M shares (1 derivative) of Solid Biosciences Inc. (SLDB) at $0.00 Transaction Date: Mar 09, 2026 | Filing ID: 102076